Core Viewpoint - The Chinese government emphasizes the importance of improving people's livelihoods as part of its modernization efforts, focusing on equitable development and common prosperity [1]. Group 1: Urban Renewal and Community Development - The government is actively implementing urban renewal actions during the 14th Five-Year Plan, particularly focusing on the renovation of old residential communities to enhance living standards [4]. - In Shenyang, the renovation of the Chang'an community has significantly improved residents' quality of life, with upgrades to heating and other utilities [1][4]. - The Ministry of Housing and Urban-Rural Development is prioritizing projects that directly impact citizens' interests, aiming to eliminate safety hazards and improve living environments [4]. Group 2: Elderly Care and Social Services - Hebei's Shijiazhuang has developed a comprehensive home-based elderly care service network, creating a 15-minute service radius for senior citizens [4]. - The city has established standardized community elderly service centers to provide various support services, including meal delivery and health guidance [4]. - The government is reforming elderly care services to ensure that the elderly are well cared for and can contribute to society [5]. Group 3: Employment and Economic Stability - The government has introduced policies to promote high-quality employment, aiming for an annual urban job creation target of over 12 million, with 10.57 million jobs created in the first three quarters of this year [5]. - The Ministry of Human Resources and Social Security is focusing on income distribution to ensure that hard work and skills are rewarded, particularly in high-demand sectors [6]. Group 4: Family Support and Childcare - The government has launched various policies, including childcare subsidies and free preschool education, to reduce the financial burden on families [5]. - These initiatives are part of a broader strategy to support families and ensure that children receive proper care and education [5]. Group 5: People's Well-being and Governance - The government is committed to placing people's needs at the forefront of its policies, ensuring that quality of life continues to improve as a primary goal of economic and social development [7]. - President Xi Jinping has reiterated the importance of addressing the public's basic needs, such as education, elderly care, and job opportunities, as essential to achieving a happy life for all [7].

央广网北京12月11日消息（记者朱宏源）据中央广播电视总台中国之声《新闻和报纸摘要》报道， 全国第十二届残疾人运动会暨第九届特殊奥林匹克运动会12月10日进入全面开赛后的第二个比赛日，共 产生121枚金牌，多人次超世界纪录、创全国纪录。 田径赛场上，江苏队选手邹莉娟在女子标枪F34级决赛中以22.73米的成绩夺冠，超过了她去年在巴 黎残奥会上创下的世界纪录。浙江队选手薛恩慧在女子铁饼F11级决赛中掷出41.33米，同样以超世界纪 录的成绩夺冠。 游泳赛场上多次刷新全国纪录。巴黎残奥会冠军蒋裕燕在10日的比赛中收获两枚金牌。 特奥滚球项目10日迎来首个决赛日，黑龙江特奥滚球队王凯/韩旭组合力压群雄摘得男子双打金 牌，程彦辑和王新雨发挥稳定，斩获该项目铜牌。 10日进行的盲人柔道项目共产生7枚金牌。最终江西队、湖南队各收获两枚金牌。皮划艇赛场产生9 枚金牌，云南队斩获5金成最大赢家。 ...

国家卫生健康委基层司运行评价处处长胡同宇：一些地方在县乡两级或者城市二三级医院与社区机 构之间用药目录、用药品种衔接，对于少数重症可以及时转诊到二三级医院，基层机构是完全能够接得 住、看得好的。 在浙江、湖南等省，疾控部门探索推进流感疫苗便捷接种服务。 央广网北京12月11日消息（记者杜希萌 李思默）据中央广播电视总台中国之声《新闻和报纸摘 要》报道，近期，我国流感活动持续处于高位，各级医疗卫生机构多措并举破解"就医难"，疾控部门部 署优化流感疫苗接种服务，方便高危人群尽快接种流感疫苗。 早上8点，山东省青岛市妇女儿童医院诊室里，不少家长已经带着孩子候诊。青岛市妇女儿童医院 副院长韩春山说，他们通过诊前检验检查，节省患者等候时间。 韩春山：确保儿科医生、诊室、床位、重症监护、药品等医疗资源配置能及时到位，面对周末、夜 间急诊人员较集中的情况，适时增加就诊单元，目前医疗运行良好。 在北京，社区医疗卫生机构成为承接流感等冬季呼吸道感染患者的"主力军"之一。数据显示，北京 市目前有369家社区卫生服务中心可提供儿科诊疗服务。同时通过分级诊疗等手段有效实现了上下级医 院间的快速转诊。 浙江省疾病预防控制中心免疫规划所 ...

央广网北京12月11日消息 据中央广播电视总台中国之声《新闻和报纸摘要》报道，多国媒体刊文 严厉抨击日本首相高市早苗导致地区局势紧张、美化侵略历史的行径。日本《每日新闻》刊文称，高市 的涉台错误言论导致地区局势紧张，且看不出对此有任何反省。在之前的党首辩论中，高市只是强 调"通过对话来构建更加良好的日中关系"，却未能提出具体措施。 俄罗斯《莫斯科共青团员报》刊文指出，高市此前发表的涉台错误言论并非失言，而是日本持续推 动修正二战战败结果的又一动作。文章警告，日本的扩军、谋求核武等倾向可能危及地区安全，呼吁俄 中及周边国家加强协调，抵制日本复活军国主义的动向。 东盟中国投资促进会会长陈荣立在马来西亚《星洲网》撰文表示，高市在吉隆坡向战死日军的"慰 灵碑"献花，此举激起马来西亚乃至整个东南亚地区人民公愤。高市应为日军的侵略史公开道歉，而非 通过政治伎俩，扭曲事实。 ...

海南省委深改办表示，本轮测评从12月2日开始到10日，主要针对"二线口岸"和非设关地合成演练 和7×24小时热运行情况，以及在此前第1、2轮测评中发现问题的整改情况开展。 测评组认为，此前测评整改事项基本完成。通关流程明显比此前测评时更加顺畅、有序，可以满足 大多数市场主体的要求。 海南省委深改办（自贸港工委办）压力测试与风险防控处工作人员金鹭：通过测评，各部门之间协 同顺畅，相关软硬件设施都已齐备，做好了封关准备。 央广网北京12月11日消息（记者董彬 金歆竹 魏安）据中央广播电视总台中国之声《新闻和报纸摘 要》报道，海南自贸港10日完成封关前压力测试成效第三方测评，这是封关前进行的最后一轮测评，封 关运作基本准备就绪。 12月10日，测评组在海口新海港和南港"二线口岸"货运集中查验场，对包括正常通关，安检异常， 海关布控等多个"二线口岸"通关的场景进行实地测评。这也是本轮测评最后一个测评点。 ...

Core Viewpoint - The rise of AI-modified videos, which alter classic film and television dialogues, poses significant challenges to traditional cultural values and intellectual property rights, as highlighted by the National Radio and Television Administration's concerns about these practices [1][6]. Group 1: AI Modification and Its Popularity - AI technology allows creators to modify classic film dialogues seamlessly, resulting in videos that can achieve millions of views and likes on short video platforms [2][3]. - The low technical barrier for creating AI-modified content has led to an explosion in the number of such videos, as users can easily generate convincing voiceovers and character animations [4][5]. Group 2: Legal and Ethical Implications - The legal boundaries of using AI-modified content remain unclear, with potential infringement risks depending on the context of use, such as whether the modification serves a critical or satirical purpose [6][7]. - The first case of AI voice infringement in China resulted in a ruling that recognized the original voice actor's rights, emphasizing the need for legal frameworks to protect against unauthorized use of voice and likeness [5][6]. Group 3: Industry Perspectives - Industry experts express concerns that AI-modified content undermines the original works' integrity and cultural significance, raising ethical questions about the motivations behind such creations [6][7]. - The proliferation of AI tools for content creation has led to a lack of awareness regarding copyright issues, with many creators operating under the assumption that they will not face legal repercussions [7].

Core Viewpoint - The Chinese government will ban the production of mercury thermometers and blood pressure monitors starting January 1, 2026, due to health and environmental concerns related to mercury toxicity [1][4][6]. Industry Impact - Many medical device manufacturers are currently experiencing a supply shortage of mercury thermometers as demand has surged in anticipation of the ban [1][3]. - Companies have been gradually reducing production of mercury thermometers since 2020, preparing for the transition to alternative products [6]. Health Concerns - Mercury is highly toxic and poses significant health risks, particularly to vulnerable populations such as children and pregnant women [4][5]. - The inhalation of mercury vapor can lead to severe health issues, including neurological damage and respiratory problems [4][5]. Alternatives to Mercury Products - The industry is shifting towards non-mercury alternatives, such as electronic thermometers and infrared thermometers, which have become widely accepted and are considered reliable [6][7]. - Recommendations for alternative products include infrared ear thermometers for children and electronic contact thermometers for the elderly, which provide accurate readings and are user-friendly [7].

素材来源｜中共中央新闻发布会介绍和解读党的二十届四中全会精神（声音实录）；画面及配乐由AI辅助生成 总监制｜张军 于锋 监制｜王薇 张琼文 刘雷 策划｜刘尚 张润晨（实习） AIGC技术｜魏星宇 吕子娴 刘思岐 10月28日，《中共中央关于制定国民经济和社会发展第十五个五年规划的建议》公布。这是乘势而上、接续推进中国式现代化建设的又一次总动 员、总部署。 "十五五"规划建议从高质量发展、科技自立自强、进一步全面深化改革等七大维度，系统勾勒出未来五年经济社会发展的清晰路径，亦为2035年 远景目标铺就坚实的台阶。 历史的笔，落于此刻；奋斗的路，通向远方。蓝图越绘越精，步伐越走越实。唯以奋斗接续奋斗，以实干成就未来。 ...

Core Viewpoint - China Life Insurance Company has achieved a significant milestone with total premium income exceeding 700 billion yuan, reflecting its commitment to providing insurance services that safeguard the public and contribute to national prosperity [1][14]. Group 1: Business Performance - As of November 30, the total premium scale of China Life surpassed 700 billion yuan, marking a substantial growth from 600 billion yuan [1][14]. - The company has provided insurance services to over 600 million customers, with long-term effective policies exceeding 300 million [3][15]. - By the first half of 2025, the company reported over 48 million claims, with total claim payments reaching 160.9 billion yuan, including over 34 billion yuan for health insurance [3][15]. Group 2: Rural and Urban Support - China Life has deployed 965 village support staff and invested over 24 million yuan in consumption assistance to help farmers increase production and income [2]. - The company has developed agricultural insurance products covering 205 million rural residents, providing a total insurance amount of 23.92 trillion yuan to mitigate poverty risks [2]. - In urban areas, China Life has launched various insurance products targeting gig economy workers and has participated in over 140 commercial medical insurance projects across cities [2]. Group 3: Health and Elderly Care Services - China Life is expanding its health and elderly care service ecosystem, offering diverse financial products to meet the growing demand for elderly care amid an aging population [4][5]. - The company has initiated over 70 long-term care insurance projects and has seen significant growth in personal pension premiums [5]. - The company has developed a range of elderly care products and services, including travel and online assistance, to enhance the quality of life for seniors [4][5]. Group 4: Digital Transformation and Customer Experience - China Life has embraced digital transformation, with over 160 million registered users on its insurance app, enhancing service efficiency and customer experience [8]. - The company has achieved a 95.56% intelligent underwriting review rate and a 95% accuracy rate for its new intelligent customer service chatbot [8]. - The company has maintained high customer satisfaction, ranking first in service quality index for two consecutive years [8]. Group 5: Investment in the Real Economy - China Life has invested 2 billion yuan in a perpetual bond investment plan to support the operational funding of the Beijing Metro Line 6 [10][11]. - The company has established a 100 billion yuan technology innovation fund to invest in strategic emerging industries, contributing to the high-quality development of the real economy [11]. - As of September 2025, the total assets of China Life reached 74,179.81 billion yuan, with investment assets amounting to 72,829.82 billion yuan [11]. Group 6: Commitment to Green Development - China Life has invested 3.6 billion yuan in a green equity investment plan to support clean energy projects, including wind and solar power [12][13]. - The company has developed a comprehensive green insurance service system, with green insurance premiums exceeding 400 million yuan in the first half of 2025 [13]. - China Life has received an AA ESG rating from MSCI, reflecting its commitment to sustainable and responsible business practices [13]. Group 7: Industry Leadership and Regulatory Compliance - The insurance industry in China has seen a 61.7% increase in total claims during the 14th Five-Year Plan period, with China Life achieving a premium growth from 600 billion to 700 billion yuan [14]. - The company has implemented a robust risk management system, maintaining an A rating in risk management for 29 consecutive quarters [14][15]. - China Life is actively responding to regulatory requirements and enhancing its operational efficiency to ensure sustainable growth [15].

Core Insights - The National Healthcare Security Administration (NHSA) has released the 2025 National Medical Insurance Drug List, adding 114 new drugs, including 50 innovative drugs of Class A, and 19 drugs included in the first commercial insurance innovative drug list [1][4] Summary by Sections New Drug Additions - The 2025 National Medical Insurance Drug List primarily adds chemical drugs, with a rapid increase in biological products and some traditional Chinese medicine [1] - Out of the 114 new drugs, 112 were included through negotiation and bidding, while 2 were directly included from national procurement [1] - A total of 111 new drugs were approved in the last five years, with the number of Class A innovative drugs reaching a historical high of 50 [1] Financial Impact - As of October 2023, the NHSA has paid over 460 billion yuan for drugs under agreement, benefiting over 1 billion patients and driving related sales exceeding 670 billion yuan [2] - Basic medical insurance covers approximately 44% of the costs for innovative drugs, while commercial insurance covers about 7% [2] Evaluation and Selection Criteria - The selection process for new drugs has seen a low pass rate during expert reviews, with only 127 out of 311 drugs passing to the negotiation table this year [2] - Some drugs were not favored due to "involutionary innovation," where the clinical value does not significantly improve compared to existing drugs [3][4] - To be included in the list, drugs must meet at least one of three criteria: filling clinical gaps, superior efficacy, or better cost-effectiveness [4] Commercial Insurance Innovations - The newly introduced commercial health insurance innovative drug list emphasizes drug innovation and clinical value, with 19 out of 141 submitted drugs successfully negotiated for inclusion [5] - The drugs in the commercial insurance list include 9 Class A new drugs, addressing gaps in basic medical insurance coverage [5] Future Directions - The NHSA plans to continue annual adjustments to the drug list to meet evolving clinical needs and incorporate advancements in medical technology [6] - The focus will be on supporting domestic and innovative drugs, enhancing collaboration between commercial insurance and innovative pharmaceutical companies [6]